Lost Money on WEBTOON Entertainment Inc. (WBTN)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky

NEW YORK, NY / ACCESSWIRE / October 15, 2024 / If you suffered a loss on your WEBTOON Entertainment Inc. (NASDAQ:WBTN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/webtoon-entertainment-inc-lawsuit-submission-form?prid=108424&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call […]

ELAN SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Elanco Animal Health Incorporated Stockholders Have Opportunity to Lead Class Action Lawsuit!

NEW YORK CITY, NY / ACCESSWIRE / October 15, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Elanco Animal Health Incorporated ("Elanco" or "the Company") (NYSE:ELAN) and certain of its officers. Class Definition This lawsuit seeks to recover damages against

IREN Stockholders Have Opportunity to Lead Iris Energy Limited Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!

NEW YORK CITY, NY / ACCESSWIRE / October 15, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Iris Energy Limited ("Iris Energy" or "the Company") (NASDAQ:IREN) and certain of its officers. Class Definition This lawsuit seeks to recover damages against

AILE STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that iLearningEngines, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit!

NEW YORK CITY, NY / ACCESSWIRE / October 15, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against iLearningEngines, Inc. ("iLearningEngines" or "the Company") (NASDAQ:AILE) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for

SUNLQ INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Investors of Sunlight Financial Holdings, Inc. f/k/a Spartan Acquisition Corp. II to Contact the Firm Today!

NEW YORK CITY, NY / ACCESSWIRE / October 15, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Sunlight Financial Holdings, Inc. f/k/a Spartan Acquisition Corp. II ("Sunlight Financial" or "the Company") (OTCMKTS:SUNLQ) and certain of its officers. Class Definition This

DPZ INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Shareholders of Domino’s Pizza Inc to Contact the Firm Today!

NEW YORK CITY, NY / ACCESSWIRE / October 15, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Domino’s Pizza Inc ("Domino’s" or "the Company") (NYSE:DPZ) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants

NLS Pharmaceutics Ltd. Announces Closing of Private Placement and Expected Compliance with Nasdaq Continued Listing Rules

ZURICH, SWITZERLAND / ACCESSWIRE / October 15, 2024 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervous system disorders, today announced the closing of a private placement offering consisting of the issuance and

Aclara Announces Update on its Rare Earths Separation Project

TORONTO, ON / ACCESSWIRE / October 15, 2024 / Aclara Resources Inc. ("Aclara" or the "Company") (TSX:ARA) is pleased to announce the completion of a conceptual engineering study for its rare earths ("REE") separation project, currently being developed by its U.S.-based subsidiary, Aclara Technologies. The separation flowsheet concept, based on solvent extraction, was developed in

GB Sciences Signs Licensing Deal With EndoPure Life Sciences for 5% Gross Sales Royalty & Sponsorship of First-in-Human Trial for Their Cannabinoid-Based Parkinson’s Drug

As a part of their Exclusive Licensing Deal, EndoPure Life Sciences will finance and sponsor first-in-human clinical trials, which help to advance GB Sciences’ cannabinoid-based products globally. LAS VEGAS, NV / ACCESSWIRE / October 15, 2024 / GB Sciences, Inc. (OTCQB:GBLX), a leading data-driven, plant-inspired biopharmaceutical development company, has signed an exclusive licensing deal with

FNA STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Paragon 28, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit!

NEW YORK CITY, NY / ACCESSWIRE / October 15, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Paragon 28, Inc. ("Paragon 28" or "the Company") (NYSE:FNA) and certain of its officers. Class Definition This lawsuit seeks to recover damages against

Scroll to Top